Apogee Therapeutics, Inc. APGE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

54/100

3/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Apogee Therapeutics, Inc. (APGE), dont 12 achats et 38 ventes. Le total des achats d'initiés s'élève à $36.44M et le total des ventes d'initiés à $141.26M.

Les initiés notables ayant une activité récente comprennent Henderson Jane, Dambkowski Carl, Henderson Michael Thomas. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — APGE

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Henderson Jane	Chief Financial Officer	Vente Informative	1,100	$85.46	$94.01K	177,371
2026-04-01	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	4,125	$22.86	$94.3K	127,165
2026-03-25	Henderson Jane	Chief Financial Officer	Vente Informative	2,000	$85.00	$170K	179,371
2026-03-11	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	3,418	$75.86	$259.29K	1,152,987
2026-03-04	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	4,125	$22.86	$94.3K	131,290
2026-03-02	Henderson Jane	Chief Financial Officer	Vente Informative	406	$71.66	$29.09K	181,371
2026-02-11	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	955	$64.99	$62.07K	1,172,987
2026-02-04	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	4,125	$22.86	$94.3K	135,415
2026-02-02	Henderson Jane	Chief Financial Officer	Vente Informative	100	$66.89	$6.69K	183,371
2026-01-22	Fairmount Funds Management Llc	Director	Vente Informative	1,750,000	$76.30	$133.53M	298,647
2026-01-14	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	470	$83.79	$39.38K	1,192,987
2026-01-07	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	14,025	$22.86	$320.61K	139,540
2026-01-06	Henderson Jane	Chief Financial Officer	Vente Informative	2,000	$80.00	$160K	185,371
2026-01-02	Henderson Jane	Chief Financial Officer	Attribution de RSU	83,690	$75.78	$6.34M	83,690
2026-01-02	Henderson Michael Thomas	Chief Executive Officer	Attribution de RSU	253,016	$75.78	$19.17M	253,016
2026-01-02	Dambkowski Carl	Chief Medical Officer	Attribution de RSU	83,690	$75.78	$6.34M	83,690
2025-12-19	Henderson Jane	Chief Financial Officer	Vente Informative	1,500	$80.00	$120K	193,371
2025-12-10	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	560	$76.58	$42.88K	1,212,987
2025-12-04	Henderson Jane	Chief Financial Officer	Vente Informative	1,500	$75.00	$112.5K	194,871
2025-12-04	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	40,000	$75.01	$3M	1,232,987
2025-12-04	Dambkowski Carl	Chief Medical Officer	Vente Informative	10,900	$75.00	$817.5K	271,108
2025-11-25	Henderson Jane	Chief Financial Officer	Vente Informative	1,500	$70.00	$105K	196,371
2025-11-14	Henderson Jane	Chief Financial Officer	Vente Informative	2,000	$65.00	$130K	197,871
2025-11-13	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	100	$64.52	$6.45K	1,272,987
2025-11-11	Henderson Jane	Chief Financial Officer	Vente Informative	1,000	$60.00	$60K	199,871
2025-11-05	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	8,060	$22.86	$184.25K	153,565
2025-10-10	Shah Nimish P	Director	Achat Informatif	365,853	-	-	365,853
2025-10-01	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	2,385	$22.86	$54.52K	161,625
2025-09-03	Dambkowski Carl	Chief Medical Officer	Vente Informative	190	$38.55	$7.32K	233,548
2025-08-06	Dambkowski Carl	Chief Medical Officer	Vente Informative	2,725	$37.78	$102.95K	236,273
2025-07-02	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	7,365	$22.86	$168.36K	164,010
2025-06-17	Jones William A Jr	Director	Attribution de RSU	14,461	$41.66	$602.45K	14,461
2025-06-17	Shah Nimish P	Director	Attribution de RSU	14,461	$41.66	$602.45K	14,461
2025-06-17	Mckenna Mark C.	Director	Attribution de RSU	14,461	$41.66	$602.45K	14,461
2025-06-17	Fairmount Funds Management Llc	Director	Attribution de RSU	14,461	$41.66	$602.45K	14,461
2025-06-17	Fox Jennifer A.	Director	Attribution de RSU	14,461	$41.66	$602.45K	14,461
2025-06-17	Gottesdiener Andrew	Director	Attribution de RSU	14,461	$41.66	$602.45K	14,461
2025-06-17	Bollinger Lisa	Director	Attribution de RSU	14,461	$41.66	$602.45K	14,461
2025-06-04	Dambkowski Carl	Chief Medical Officer	Vente Informative	2,725	$36.96	$100.72K	241,723
2025-05-07	Dambkowski Carl	Chief Medical Officer	Vente Informative	2,725	$35.75	$97.42K	244,448
2025-04-02	Dambkowski Carl	Chief Medical Officer	Vente Informative	889	$37.59	$33.42K	247,173
2025-03-05	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	2,674	$30.62	$81.88K	1,292,987
2025-03-05	Dambkowski Carl	Chief Medical Officer	Vente Informative	1,590	$30.48	$48.46K	251,033
2025-02-05	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	15,000	$40.58	$608.7K	1,302,987
2025-02-05	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	795	$22.86	$18.17K	171,375
2025-01-31	Henderson Michael Thomas	Chief Executive Officer	Exercice d'Options (Vente)	8,500	$22.86	$194.31K	390,012
2025-01-08	Henderson Michael Thomas	Chief Executive Officer	Vente Informative	2,868	$49.38	$141.62K	1,309,487
2025-01-02	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	1,360	$22.86	$31.09K	172,170
2024-12-12	Mckenna Mark C.	Director	Achat Informatif	7,500	$49.02	$367.65K	7,500
2024-12-11	Dambkowski Carl	Chief Medical Officer	Exercice d'Options (Vente)	1,815	$22.86	$41.49K	173,530

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration